Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Be diagnosed with chronic PTSD, duration of 6 months or longer resulting from traumatic experience during military service;~* Have a CAPS score showing moderate to severe PTSD symptoms;~* Have had at least one unsuccessful attempt at treatment for PTSD either with talk therapy or with drugs, or discontinuing treatment because of inability to tolerate psychotherapy or drug therapy.~* Are at least 18 years old;~* Must be generally healthy;~* Must sign a medical release for the investigators to communicate directly with their therapist and doctors;~* Are willing to refrain from taking any psychiatric medications during the study period;~* Willing to follow restrictions and guidelines concerning consumption of food, beverages, and nicotine the night before and just prior to each experimental session;~* Willing to remain overnight at the study site;~* Agree to have transportation other than driving themselves home or to where they are staying after the integrative session on the day after the MDMA session;~* Are willing to be contacted via telephone for all necessary telephone contacts;~* Must have a negative pregnancy test if able to bear children, and agree to use an effective form of birth control;~* Must provide a contact in the event of a participant becoming suicidal;~* Are proficient in speaking and reading English;~* Agree to have all clinic visit sessions recorded to audio and video~* Agree not to participate in any other interventional clinical trials during the duration of this study.~Exclusion Criteria:~5.3.2 Exclusion Criteria:~* Are pregnant or nursing, or if a woman who can have children, those who are not practicing an effective means of birth control;~* Weigh less than 48 kg;~* Are abusing illegal drugs;~* Are unable to give adequate informed consent;~* Upon review of past and current drugs/medication must not be on or have taken a medication that is exclusionary.~* Upon review of medical or psychiatric history must not have any current or past diagnosis that would be considered a risk to participation in the s

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Low dose MDMA (Type: ACTIVE_COMPARATOR): Participants will receive 30 mg MDMA during each of two blinded experimental sessions.
- Medium dose MDMA (Type: ACTIVE_COMPARATOR): Participants will receive 75 mg MDMA on each of two blinded experimental sessions
- Full dose MDMA (Type: EXPERIMENTAL): Participants will receive 125 mg MDMA during each of two blinded experimental sessions, followed by a third open label session.

Based on this trial design, predict the completion outcome and termination type (if applicable).